Main Line Ctr-Oral & Facial is categorized under Doctors in Paoli, PA .
Main Line Ctr-Oral & Facial was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6212100 by the NAICS.
If you are seeking more information, feel free to contact Linda Passaralla, Office Manager at the company’s single location by writing to 21 Industrial Boulevard # 100, Paoli, Pennsylvania PA 19301 or by phoning (610) 644-6497. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Main Line Ctr-Oral & Facial |
| Contact Person: | Linda Passaralla, Office Manager |
| Address: | 21 Industrial Boulevard # 100, Paoli, Pennsylvania 19301 |
| Phone Number: | (610) 644-6497 |
| Website Address: | mloms.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6212100 |
| Share This Business: |
Main Line Ctr-Oral & Facial was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6212100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Linda Passaralla, Office Manager for inquiries that concern Main Line Ctr-Oral & Facial by calling the company number (610) 644-6497, as your correspondence is most welcome. Additionally, the physical location of the single location of Main Line Ctr-Oral & Facial can be found at the coordinates 40.047969,-75.497994 as well as the street address 21 Industrial Boulevard # 100 in Paoli, Pennsylvania 19301.
For its online presence, you may visit Main Line Ctr-Oral & Facial’s website at mloms.com and engage with its social media outlets through on Twitter and on Facebook.